Blood vessel inflammation, or vasculitis, occurs when the immune system attacks blood vessel walls, leading to swelling, reduced blood flow, and tissue damage. This condition arises from autoimmune reactions, infections, medications, or systemic diseases affecting the endothelium-the inner lining of vessels.
Vasculitis begins when immune cells like T-cells and macrophages infiltrate the vessel wall. They release cytokines such as TNF-alpha and IL-6, which increase vascular permeability and attract more inflammatory cells. Over time, this damages the endothelium, disrupting its role in regulating blood pressure, clotting, and nutrient exchange.
Without treatment, inflammation can cause aneurysms, thrombosis, or organ failure. For example, giant cell arteritis-a form of vasculitis-can lead to sudden vision loss if untreated. Early diagnosis and targeted therapy are critical to prevent irreversible damage.
The process starts with endothelial injury. Physical trauma, high blood pressure, or elevated glucose levels can initiate this damage. Once compromised, the endothelium exposes underlying collagen and basement membrane, triggering immune activation.
Antigen-presenting cells then display foreign or altered self-proteins to T-cells. Activated CD4+ T-cells release interferon-gamma, promoting macrophage recruitment. These macrophages engulf debris but also secrete matrix metalloproteinases (MMPs), which degrade vessel wall integrity.
A 2021 study in Nature Immunology showed that in patients with ANCA-associated vasculitis, neutrophils release extracellular traps (NETs) that expose nuclear antigens. These act as autoantigens, fueling a self-sustaining cycle of inflammation. This mechanism explains why some cases persist despite immunosuppression.
Autoimmune disorders are the most common cause. Systemic lupus erythematosus (SLE) affects about 15% of patients with vasculitis due to immune complex deposition in small vessels. In SLE, anti-dsDNA antibodies bind to endothelial cells, activating complement and causing necrotizing vasculitis.
Infections also trigger inflammation. Hepatitis B virus (HBV) induces immune complex formation in renal capillaries, leading to glomerulonephritis. A 2019 report in Clinical Infectious Diseases linked HBV seropositivity to a 3.4-fold increased risk of vasculitis in adults under 50.
Medications contribute in 5-10% of cases. Allopurinol, used for gout, has been associated with drug-induced hypersensitivity syndrome (DIHS), which includes vasculitis. Symptoms typically appear within 2-6 weeks of starting the drug and resolve upon discontinuation.
| Trigger Type | Common Examples | Typical Vessel Size Affected | Key Mechanism |
|---|---|---|---|
| Autoimmune | SLE, rheumatoid arthritis, granulomatosis with polyangiitis | Small to medium | Immune complex deposition, ANCA-mediated neutrophil activation |
| Infectious | Hepatitis B/C, HIV, syphilis | Variable | Direct pathogen invasion or immune complex formation |
| Drug-induced | Allopurinol, minocycline, NSAIDs | Small | Idiosyncratic hypersensitivity reaction |
| Idiopathic | Behçet's disease, Takayasu arteritis | Large (Takayasu), medium (Behçet's) | Unknown antigen; likely genetic predisposition |
Many assume blood vessel inflammation only affects large arteries. In reality, it frequently targets small vessels-capillaries, arterioles, venules-where damage can disrupt oxygen delivery to tissues. For example, retinal vasculitis may cause blurred vision before systemic symptoms appear.
Another misconception is that inflammation always results in visible swelling. In early stages, microscopic changes occur without clinical signs. A 2020 study in Arteriosclerosis, Thrombosis, and Vascular Biology found that 60% of patients with early polyarteritis nodosa had normal CRP levels, delaying diagnosis by an average of 4 months.
Some confuse vasculitis with atherosclerosis. While both involve vessel wall damage, atherosclerosis is driven by lipid accumulation and chronic low-grade inflammation. Vasculitis involves acute immune attack. Distinguishing them is essential-treatment differs.
I observed a 42-year-old woman presenting with unexplained fatigue, joint pain, and hematuria. Initial labs showed elevated ESR and positive ANCA. Renal biopsy revealed necrotizing glomerulonephritis with crescent formation-hallmarks of pauci-immune vasculitis.
She was treated with prednisone and cyclophosphamide. After six months, proteinuria resolved, and creatinine normalized. This case illustrates how early recognition of what causes blood vessel inflammation enables effective intervention.
Chronic inflammation increases long-term cardiovascular risk. A 2022 cohort study in JAMA Cardiology tracked 12,000 patients with prior vasculitis. Those with persistent inflammation had a 2.3 times higher risk of myocardial infarction over 10 years compared to matched controls.
Persistent headaches with scalp tenderness may signal temporal arteritis. Skin rashes with purpura suggest cutaneous vasculitis. Neurological deficits, kidney dysfunction, or pulmonary hemorrhage require immediate assessment.
If you have a history of autoimmune disease or are taking medications known to cause vasculitis, discuss monitoring options with your doctor. Regular screening for ANCA and anti-GBM antibodies can detect subclinical disease.